University of North Carolina at Chapel Hill — Chapel Hill, North Carolina

Public research footprint of University of North Carolina at Chapel Hill, compiled from the ClinicalTrials.gov public registry.

1,225

Registered studies

317

Active

199

Recruiting now

742

Completed

141

Stopped or withdrawn

Most-studied conditions

Acute Respiratory Distress Syndrome (ARDS) · Heart Failure · Squamous Cell Carcinoma of Head and Neck · Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia

Recently updated registry entries

NCT06654752 — Streamlined Treatment of Pulmonary Exacerbations in Pediatrics (Recruiting)
NCT06447168 — A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in… (Recruiting)
NCT07332091 — Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of North Carolina at Chapel Hill?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.